In this Issue:
Interim PET-CT guided therapy in Hodgkin lymphoma
Genomic classification and prognosis in AML
Rituximab and dose-dense chemo for Burkitt’s lymphoma
Lymphocytosis after dasatinib therapy in CML
ABVD8 vs BEACOPP4+4 in Hodgkin lymphoma
Venetoclax in relapsed/ refractory CLL with 17p deletion
An international prognostic index for CLL
Ponatinib vs imatinib in newly diagnosed CML
First-line dasatinib plus chemo in adult Ph-positive ALL
Reduced intensity autoSCT for relapsed follicular lymphoma
Please login below to download this issue (PDF)